September 2025
1. SERBAN M, Spampinato S, de Leeuw A, Fortin I, et al
   Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis.
   Radiother Oncol. 2025;210:110954.
   

   >> Share

   
   August 2025
2. CORBEAU A, Astreinidou E, Kuipers SC, Wielopolski PA, et al
   Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy.
   Radiother Oncol. 2025;211:111089.
   

   >> Share

   
   July 2025
3. ROSSI L, Bijman R, Westerveld H, Christianen M, et al
   Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy.
   Radiother Oncol. 2025;210:111029.
   

   >> Share

   
   March 2025
4. DE HOND YJM, van Haaren PMA, Verrijssen AE, Tijssen RHN, et al
   Dosimetric evaluation of variation in Library of plans selection for cervical cancer radiotherapy.
   Radiother Oncol. 2025;206:110835.
   

   >> Share

   
   
5. JAIN J, Serban M, Assenholt MS, Hande V, et al
   Can knowledge-based planning models validated on ethnically diverse patients lead to global standardisation of external beam radiation therapy for locally advanced cervix cancer?
   Radiother Oncol. 2025;204:110694.
   

   >> Share

   
   February 2025
6. GAO H, Wu H, Zhang Y, Wang S, et al
   Dose-volume constraints for severe acute gastrointestinal toxicity in cervical cancer patients receiving extended-field intensity-modulated radiotherapy and concurrent chemotherapy.
   Radiother Oncol. 2025 Feb 4:110777. doi: 10.1016/j.radonc.2025.110777.
   

   >> Share

   
   January 2025
7. LIU Y, Chen Z, Zhou Q, Shang X, et al
   A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose.
   Radiother Oncol. 2025;202:110593.
   

   >> Share

   
   December 2024
8. WU Z, Lu L, Xu C, Wang D, et al
   Development and external validation of a multi-task feature fusion network for CTV segmentation in cervical cancer radiotherapy.
   Radiother Oncol. 2024;204:110699.
   

   >> Share

   
   August 2024
9. NI R, Han K, Haibe-Kains B, Rink A, et al
   Generalizability of deep learning in organ-at-risk segmentation: A transfer learning study in cervical brachytherapy.
   Radiother Oncol. 2024;197:110332.
   

   >> Share

   
   July 2024
10. MARSILLA J, Weiss J, Ye XY, Welch M, et al
    A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study.
    Radiother Oncol. 2024;199:110463.
    

    >> Share

    
    May 2024
11. AI Y, Zhu X, Zhang Y, Li W, et al
    MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer.
    Radiother Oncol. 2024;197:110328.
    

    >> Share

    
    March 2024
12. SKIPAR K, Hompland T, Lund KV, Lindemann K, et al
    Mri-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
    Radiother Oncol. 2024 Mar 29:110263. doi: 10.1016/j.radonc.2024.110263.
    

    >> Share

    
    
13. KUIPERS SC, Godart J, Corbeau A, Breedveld S, et al
    Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 10:110222. doi: 10.1016/j.radonc.2024.110222.
    

    >> Share

    
    
14. HUI C, Ewongwo A, Mendoza MG, Kozak MM, et al
    Less than whole uterus irradiation for patients with locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 2:110199. doi: 10.1016/j.radonc.2024.110199.
    

    >> Share

    
    November 2023
15. REIJTENBAGH D, Godart J, Penninkhof J, Quint S, et al
    Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques.
    Radiother Oncol. 2023;190:110009.
    

    >> Share

    
    September 2023
16. NOUT R, Calaminus G, Planchamp F, Chargari C, et al
    ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer.
    Radiother Oncol. 2023;186:109662.
    

    >> Share

    
    July 2023
17. CIBULA D, Rosaria Raspollini M, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Radiother Oncol. 2023;184:109682.
    

    >> Share

    
    June 2023
18. ECKER S, Kirisits C, Schmid M, Knoth J, et al
    EviGUIDE - A tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer.
    Radiother Oncol. 2023 Jun 15:109748. doi: 10.1016/j.radonc.2023.109748.
    

    >> Share

    
    
19. CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al
    ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
    Radiother Oncol. 2023;183:109589.
    

    >> Share

    
    March 2023
20. OKAMOTO H, Murakami N, Isohashi F, Kasamatsu T, et al
    Plan quality association between dummy run and individual case review in a prospective multi-institutional clinical trial of postoperative cervical cancer patients treated with intensity-modulated radiotherapy: Japan Clinical Oncology Group study (JCO
    Radiother Oncol. 2023 Mar 17:109630. doi: 10.1016/j.radonc.2023.109630.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share